Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Vipergen ApS
French AI-driven drug design firm will employ multiple technology platforms in latest tie-ups. Apellis looks to augment Empaveli-led portfolio in C3 complement R&D alliance with Affilogic.
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
- Drug Discovery Tools
- Other Names / Subsidiaries